1005342-47-1 Usage
Description
(S)-N-((S)-1-cyclohexyl-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(MethylaMino)propanaMide, also known as TAK-063, is a chemical compound that serves as a selective phosphodiesterase 10A (PDE10A) inhibitor. (S)-N-((S)-1-cyclohexyl-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(MethylaMino)propanaMide has the potential to regulate the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in the brain, which may contribute to therapeutic effects on various neurological and psychiatric disorders.
Uses
Used in Pharmaceutical Applications:
TAK-063 is used as a therapeutic agent for the treatment of neurological and psychiatric disorders. Its application is based on its ability to selectively inhibit PDE10A, which in turn helps regulate the levels of cAMP and cGMP in the brain. This modulation of signaling molecules may provide therapeutic benefits for conditions such as schizophrenia, Alzheimer's disease, and Parkinson's disease.
Used in Research and Drug Development:
TAK-063 is also utilized in the field of neuroscience research and drug development. Its potential applications in treating various brain-related conditions make it a valuable compound for further investigation and exploration. Researchers are actively studying its effects and mechanisms of action to better understand its potential as a therapeutic agent.
Used in Neurological Disorder Treatment:
In the treatment of neurological disorders, TAK-063 is used as a selective PDE10A inhibitor to help regulate the levels of cAMP and cGMP. This regulation may contribute to the amelioration of symptoms and improvement in the quality of life for patients suffering from conditions such as Alzheimer's disease and Parkinson's disease.
Used in Psychiatric Disorder Treatment:
For psychiatric disorders, TAK-063 is used as a therapeutic agent to modulate the levels of cAMP and cGMP in the brain. This modulation may help in the treatment of conditions like schizophrenia, potentially leading to improved cognitive function and overall mental health for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 1005342-47-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,5,3,4 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1005342-47:
(9*1)+(8*0)+(7*0)+(6*5)+(5*3)+(4*4)+(3*2)+(2*4)+(1*7)=91
91 % 10 = 1
So 1005342-47-1 is a valid CAS Registry Number.
1005342-47-1Relevant articles and documents
Organic Compounds
-
Page/Page column 15, (2011/04/18)
The present invention is directed to a compound of the formula: or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.
